Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer
Open Access
- 5 February 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (17) , 13501-13516
Abstract
Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancerKeywords
This publication has 35 references indexed in Scilit:
- Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck CancerJournal of Oncology, 2009
- Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissuesCancer Biology & Therapy, 2009
- Translational control: A target for cancer therapyCancer Letters, 2007
- Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?Cell Cycle, 2007
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1Experimental Cell Research, 2004
- eIF-4E expression and its role in malignancies and metastasesOncogene, 2004
- Features in the N and C Termini of the MAPK-interacting Kinase Mnk1 Mediate Its Nucleocytoplasmic ShuttlingJournal of Biological Chemistry, 2003
- Involvement of Stress-activated Protein Kinase and p38/RK Mitogen-activated Protein Kinase Signaling Pathways in the Enhanced Phosphorylation of Initiation Factor 4E in NIH 3T3 CellsJournal of Biological Chemistry, 1997
- MNK1, a new MAP kinase‐activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substratesThe EMBO Journal, 1997